article-journal

Zhang's guidelines vs WHO guidelines for diagnosing labour dystocia - Authors' reply
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial
BACKGROUND AND OBJECTIVES: The 52-week, randomized, double-blind, noninferiority, government-funded NOR-SWITCH trial demonstrated that …
Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases
OBJECTIVES: Patients with inflammatory joint diseases (IJD) have an increased risk of cardiovascular disease (CVD). Our goal was to …